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Despite decades of research, treatments for schizophrenia have largely been limited in their 
efficacy to treat hallucinations, delusions, disorganized thoughts and behaviour and related 
agitation/aggression. Apart from reduction of severity of positive symptoms, improved social 
functioning, increase patient and carer satisfaction with services and reduction in patient 
drop-out from services are some of the important goals of management. While current 
pharmacological interventions ameliorate psychotic symptoms but its effects are less so for 
disabling cognitive and motivational impairments. Specific vocational and psychological 
interventions, in combination with antipsychotic medication in a context of community-case 
management, can improve functional outcome but are not widely available. Until we have 
developed treatments that address the underlying neurobiological vulnerability and protect 
against environmental risks, we hope that society will treat those who suffer with psychosis 
with respect, hope, and dignity-rather than stigma, pessimism, and exclusion. This 
presentation provides a review and critique of currently available pharmacologic and 
psychosocial treatments in schizophrenia, and focuses on investigational treatments and 
potential strategies for future pharmacotherapy. 
